Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers
NCT04093050Phase 1Completed
- Sponsor
- Endo International plc
- Start
- Oct 2019
- Primary completion
- Apr 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label trial of vasopressin in vasodilatory shock (2 arms), sponsored by Endo International plc. Primary endpoint: Plasma Clearance of vasopressin at 15 days. Started Oct 2019; status: completed.
02
Drugs
vasopressin
03
Conditions
vasodilatory shock
Beyond the preview
Go deeper on NCT04093050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04093050.